Biomerica Inc. has reported its financial results for the fiscal year ending May 31, 2025. The company announced net sales of approximately $5.311 million, reflecting a decrease of $104,000, or 2%, compared to $5.415 million in the previous fiscal year. This decline was primarily influenced by a significant drop in over-the-counter sales, which decreased by $377,000 or 26%. Conversely, contract manufacturing sales increased by $329,000, representing a 44% rise. No information on net income, profit, loss, or earnings per share was provided in the report.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biomerica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-026041), on August 29, 2025, and is solely responsible for the information contained therein.